Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001415889-24-006473 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-03-04	2024-02-29	PCVX	GUGGENHIME ANDREW	Pres AND CFO	A - Grant	$0.00	+20.0K	99.5K	+25%	$0
D	2024-03-04	2024-03-02	PCVX	GUGGENHIME ANDREW	Pres AND CFO	F - Tax	$71.55	-3,795	95.7K	-4%	-$271.5K
D	2024-03-04	2024-02-29	PCVX	GUGGENHIME ANDREW	Pres AND CFO	A - Grant	$0.00	+90.0K	90.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-29	A	A	20,000	$0.00	99,474	D	—	—	(F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on August 31, 2024 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
2	Common	Common Stock	2024-03-02	F	D	3,795	$71.55	95,679	D	—	—	(F2) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
3	Derivative	Stock Option (right to buy)	2024-02-29	A	A	90,000	$0.00	90,000	D	$73.82 · — to 2034-02-28	90,000 Common Stock	(F3) 1/48 of shares subject to the option vest on March 31, 2024, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.